167 related articles for article (PubMed ID: 21570438)
1. Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients.
Minelli A; Zanardini R; Abate M; Bortolomasi M; Gennarelli M; Bocchio-Chiavetto L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1322-5. PubMed ID: 21570438
[TBL] [Abstract][Full Text] [Related]
2. Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.
Minelli A; Maffioletti E; Bortolomasi M; Conca A; Zanardini R; Rillosi L; Abate M; Giacopuzzi M; Maina G; Gennarelli M; Bocchio-Chiavetto L
Acta Psychiatr Scand; 2014 Jun; 129(6):461-6. PubMed ID: 23957507
[TBL] [Abstract][Full Text] [Related]
3. Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression.
Bilgen AE; Bozkurt Zincir S; Zincir S; Ozdemir B; Ak M; Aydemir E; Sener I
Brain Res Bull; 2014 May; 104():82-7. PubMed ID: 24747833
[TBL] [Abstract][Full Text] [Related]
4. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
[TBL] [Abstract][Full Text] [Related]
5. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
[TBL] [Abstract][Full Text] [Related]
6. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
[TBL] [Abstract][Full Text] [Related]
7. Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels.
Rapinesi C; Kotzalidis GD; Curto M; Serata D; Ferri VR; Scatena P; Carbonetti P; Napoletano F; Miele J; Scaccianoce S; Del Casale A; Nicoletti F; Angeletti G; Girardi P
Psychiatry Res; 2015 Jun; 227(2-3):171-8. PubMed ID: 25910420
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum vascular endothelial growth factor in treatment-resistant schizophrenia treated with electroconvulsive therapy: Positive association with therapeutic effects.
Xiao W; Zhan Q; Ye F; Tang X; Li J; Dong H; Sha W; Zhang X
World J Biol Psychiatry; 2019 Feb; 20(2):150-158. PubMed ID: 29611450
[TBL] [Abstract][Full Text] [Related]
9. Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients.
Okazaki M; Tominaga K; Higuchi H; Utagawa I; Nakamura E; Noguchi M; Itaya M; Hashimoto C; Yamaguchi N
J ECT; 2010 Jun; 26(2):87-90. PubMed ID: 19710622
[TBL] [Abstract][Full Text] [Related]
10. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
[TBL] [Abstract][Full Text] [Related]
11. VEGF serum levels in depressed patients during SSRI antidepressant treatment.
Ventriglia M; Zanardini R; Pedrini L; Placentino A; Nielsen MG; Gennarelli M; Bocchio-Chiavetto L
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):146-9. PubMed ID: 19059450
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression.
Kayser S; Bewernick BH; Grubert C; Hadrysiewicz BL; Axmacher N; Schlaepfer TE
J Psychiatr Res; 2011 May; 45(5):569-76. PubMed ID: 20951997
[TBL] [Abstract][Full Text] [Related]
13. Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients.
Lin CH; Chen MC; Lee WK; Chen CC; Huang CH; Lane HY
Neuropsychobiology; 2013; 68(2):110-5. PubMed ID: 23881232
[TBL] [Abstract][Full Text] [Related]
14. Memory performance in severely depressed patients treated by electroconvulsive therapy.
Hihn H; Baune BT; Michael N; Markowitsch H; Arolt V; Pfleiderer B
J ECT; 2006 Sep; 22(3):189-95. PubMed ID: 16957535
[TBL] [Abstract][Full Text] [Related]
15. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein.
Palmio J; Huuhka M; Laine S; Huhtala H; Peltola J; Leinonen E; Suhonen J; Keränen T
Psychiatry Res; 2010 May; 177(1-2):97-100. PubMed ID: 20378182
[TBL] [Abstract][Full Text] [Related]
16. Electroconvulsive therapy in depressive illness that has not responded to drug treatment.
Husain SS; Kevan IM; Linnell R; Scott AI
J Affect Disord; 2004 Dec; 83(2-3):121-6. PubMed ID: 15555704
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
[TBL] [Abstract][Full Text] [Related]
18. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
[TBL] [Abstract][Full Text] [Related]
19. Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy-A pilot study.
Kranaster L; Blennow K; Zetterberg H; Sartorius A
J Affect Disord; 2019 Jun; 253():449-453. PubMed ID: 31103810
[TBL] [Abstract][Full Text] [Related]
20. Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder.
Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
Brain Behav; 2021 Aug; 11(8):e02001. PubMed ID: 34342142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
